In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation

Set Alert for Innovation

Project Data Sphere Rewrites The Rules For Open Access Research On Cancer

Now that Project Data Sphere has established itself as a world-class data sharing platform, the group’s leadership is planning for its next phase of the struggle against cancer. Project Data Sphere's president Bill Louv talks to In Vivo about how the group has "raised the bar on what is possible to achieve in cancer research."

Innovation Digital Health Research and Development Strategies
Advertisement

Latest From Innovation

ImmunoGen CEO: Solving Cancer’s Access Challenge With Data, Differentiation And A Big Dose of Bipartisanship

ImmunoGen CEO Mark Enyedy, a leading proponent of targeted ADC oncologics, explains to In Vivo how high risk – and dogged resilience – are central features of a challenging innovative landscape in cancer today. Despite some recent setbacks on the road to commercialization, science will continue to transform, bolstered by the industry's financial commitments; revolutionary new data sources, validated by patient-centered outcomes; and that persistent human intangible called hope. 

C-Suite Speaks Innovation

GE Healthcare Sets Out Its Software And AI Ambitions

GE Healthcare is using its artificial intelligence platform Edison to power a new generation of medical imaging apps and devices. At the annual European Congress of Radiology (ECR), In Vivo met with Mathias Goyen, GE Healthcare’s chief medical officer, Europe, to discuss the future of AI in radiology and how technology will transform practice.

Artificial Intelligence Diagnostics

Patient-Specificity Meets Digital Ecosystems As Corin Acquires TKR Robotics Player Omni

Hip and knee replacement challenger firm Corin Group has a big ambition to revolutionize orthopedics with connected digital ecosystems and patient-specific concepts. That aim has come a step closer with its acquisition of robotic-assisted total knee replacement (TKR) company Omni Orthopaedics. Corin's Elvio Gramignano believes this approach will lead to real change in health care delivery.       

Innovation Medical Device

Virtual AI Nurses And The Future Of Chronic Disease Management

David Lee, partner at Simon-Kucher & Partners, sits down for a fireside chat with serial entrepreneur Julia Hu to talk about virtual AI nurses and the future of chronic disease management. Hu founded Lark Health in 2011 with the goal of scaling personalized, digitally driven health care to anyone in the world.

Digital Health Artificial Intelligence

Deal-Making Fires Up To Unlock Checkpoint Inhibitors’ Full Potential

Merck & Co.’s Keytruda is already elbowing its way into the top ten best-selling drugs. But it, and its expanding cohort of competitors, could be much bigger. Companies and investors are scrambling to identify the technology or technologies that can unlock checkpoint inhibitors’ potential in the 70% or more of tumors where they do not currently work. That activity is reflected across 2018’s licensing deals, M&A and financings.

ImmunoOncology Innovation

Science Matters: Merck Joins Crowded NASH Race As Several Data Readouts Loom

No NASH treatments are on the market yet, but Phase III data readouts are emerging, mid-stage drugs are demonstrating their capabilities and combinations are in view. 

Innovation Research and Development Strategies
See All
UsernamePublicRestriction

Register